Pranlukast hydrate in the treatment of pediatric bronchial asthma

Shigemi Yoshihara Department of Pediatrics, Dokkyo Medical University, Tochigi, Japan Abstract: Pranlukast hydrate is a potent, selective, orally active, cysteinyl leukotriene antagonist that binds at the type 1 receptor. It is used as a 10% dry syrup to treat asthma and allergic rhinitis in pediatr...

Full description

Bibliographic Details
Main Author: Yoshihara S
Format: Article
Language:English
Published: Dove Medical Press 2013-07-01
Series:Pediatric Health, Medicine and Therapeutics
Online Access:http://www.dovepress.com/pranlukast-hydrate-in-the-treatment-of-pediatric-bronchial-asthma-a13612